A New Cardiac Rehabilitation Treatment in the Application of Ischemic Heart Disease: a Prospective, Randomized Controlled Clinical Study

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Cardiac rehabilitation is an important link in cardiovascular disease. This study mainly explores the effectiveness of new cardiac rehabilitation therapy (early respiratory rehabilitation, phase I rehabilitation, exercise therapy, external counterpulsation, extracorporeal shock wave, etc.) on patients with ischemic heart disease such as coronary heart disease and heart failure, and the compliance of home rehabilitation compared with traditional cardiac rehabilitation therapy (traditional exercise rehabilitation, rehabilitation education, etc.).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 85
Healthy Volunteers: f
View:

• Aged between 18 and 85 years old

• Female subjects no pregnancy

• The main admission diagnosis of ischemic heart disease (coronary heart disease, myocardial infarction, ischemic heart failure, etc.)

• The need for cardiac rehabilitation treatment

Locations
Other Locations
China
Department of Cardiology, Shanghai Tenth People's Hospital
RECRUITING
Shanghai
Contact Information
Primary
liujing liu, MD, PhD
liuweijing98@sina.com
+86 18917684041
Backup
zhaoxin zhu, B.D
zhaoxinzhu0728@163.com
+86 13162999337
Time Frame
Start Date: 2024-01-01
Estimated Completion Date: 2031-12-31
Participants
Target number of participants: 100
Treatments
Experimental: The new rehabilitation group
Routine drug therapy + new cardiac rehabilitation therapy, a new cardiac rehabilitation treatment reference guide requirements, according to the actual circumstance of patients treated with 1-3 months intervention.
Active_comparator: The traditional rehabilitation group.
Routine drug therapy + traditional cardiac rehabilitation therapy, traditional cardiac rehabilitation treatment for reference domestic and international guidelines and consensus, according to the actual circumstance of patients treated with 1-3 months intervention.
Related Therapeutic Areas
Sponsors
Leads: Shanghai 10th People's Hospital
Collaborators: Shanghai Municipal Science and Technology Commission

This content was sourced from clinicaltrials.gov